v3.24.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue $ 153
Cost of revenue, excluding depreciation and amortization (886)
Depreciation and amortization (733) (503)
Research and development (2,231) (4,107)
Selling, general and administrative (14,962) (10,498)
Goodwill impairment charge (649)
Loss from operations (19,308) (15,108)
Other income (expense):    
Interest expense (9,417) (7)
Loss on extinguishment of warrant liability (504)
Loss on extinguishment of debt (2,345)
Gain on issuance of convertible notes 64
Change in fair value of warrants 10,458 1,023
Change in fair value of notes (7,040) (149)
Change in fair value of derivative liability 401
Other expense (1,293) (74)
Total other income (expense) (9,676) 793
Loss before income taxes (28,984) (14,315)
Income tax expense
Net loss (28,984) (14,315)
Deemed dividend on Series D preferred stock (6)
Net loss attributable to common stockholders $ (29,660) $ (14,370)
Net loss per share attributable to common stockholders (in Dollars per share) $ (5.46) $ (54.12)
Weighted average shares outstanding, basic (in Shares) 5,429,259 265,502
Cumulative dividends on Series A preferred stock    
Other income (expense):    
Cumulative dividends $ (19)
Cumulative dividends on Series B preferred stock    
Other income (expense):    
Cumulative dividends (107)
Cumulative dividends on Series C preferred stock    
Other income (expense):    
Cumulative dividends (30)
Cumulative dividends on Series D preferred stock    
Other income (expense):    
Cumulative dividends (53) (55)
Cumulative dividends on Series F preferred stock    
Other income (expense):    
Cumulative dividends (272)
Cumulative dividends on Series F-1 preferred stock    
Other income (expense):    
Cumulative dividends (110)
Cumulative dividends on Series F-2 preferred stock    
Other income (expense):    
Cumulative dividends $ (79)

Source